Indaptus Therapeutics (INDP) Short Interest Ratio & Short Volume $0.80 +0.03 (+3.90%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.78 -0.02 (-1.88%) As of 02/21/2025 05:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Indaptus Therapeutics Short Interest DataIndaptus Therapeutics (INDP) has a short interest of 38,700 shares, representing 0.36% of the float (the number of shares available for trading by the public). This marks a -41.72% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.6, indicating that it would take 1.6 days of the average trading volume of 26,614 shares to cover all short positions.Current Short Interest38,700 sharesPrevious Short Interest66,400 sharesChange Vs. Previous Month-41.72%Dollar Volume Sold Short$35,217.00Short Interest Ratio1.6 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares14,120,000 sharesFloat Size10,880,000 sharesShort Percent of Float0.36%Today's Trading Volume37,388 sharesAverage Trading Volume26,614 sharesToday's Volume Vs. Average140% Short Selling Indaptus Therapeutics? Sign up to receive the latest short interest report for Indaptus Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINDP Short Interest Over TimeINDP Days to Cover Over TimeINDP Percentage of Float Shorted Over Time Indaptus Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202538,700 shares $35,217.00 -41.7%0.4%1.6 $0.91 1/15/202566,400 shares $57,768.00 -11.2%0.7%0.6 $0.87 12/31/202474,800 shares $62,989.08 -19.1%0.8%0.7 $0.84 12/15/202492,500 shares $92,500.00 +0.5%1.0%0.8 $1.00 11/30/202492,000 shares $93,840.00 +8.2%1.1%0.8 $1.02 11/15/202485,000 shares $94,350.00 -38.7%1.1%0.8 $1.11 10/31/2024138,700 shares $162,279.00 +348.9%1.9%1.3 $1.17 10/15/202430,900 shares $39,243.00 -9.7%0.4%0.3 $1.27 9/30/202434,200 shares $42,408.00 +284.3%0.5%2.5 $1.24 9/15/20248,900 shares $13,439.00 +140.5%0.1%0.7 $1.51 Get the Latest News and Ratings for INDP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Indaptus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/20243,700 shares $6,095.38 -47.9%0.1%0.3 $1.65 8/15/20247,100 shares $11,857.00 -12.4%0.1%0.4 $1.67 7/31/20248,100 shares $16,519.95 -42.6%0.1%0.4 $2.04 7/15/202414,100 shares $31,020.00 +147.4%0.2%0.7 $2.20 6/30/20245,700 shares $12,084.00 +9.6%0.1%0.2 $2.12 6/15/20245,200 shares $12,844.00 -66.7%0.1%0.2 $2.47 5/31/202415,600 shares $36,972.00 -6.0%0.3%0.5 $2.37 5/15/202416,600 shares $36,686.00 -35.7%0.3%0.2 $2.21 4/30/202425,800 shares $55,986.00 -70.1%0.4%0.3 $2.17 4/15/202486,200 shares $228,430.00 -13.9%1.5%1 $2.65 3/31/2024100,100 shares $224,224.00 +0.7%1.7%1.3 $2.24 3/15/202499,400 shares $185,878.00 +196.7%1.7%1.3 $1.87 2/29/202433,500 shares $73,700.00 +94.8%0.6%0.5 $2.20 2/15/202417,200 shares $29,928.00 +18.6%0.3%1.8 $1.74 1/31/202414,500 shares $23,925.00 -20.8%0.3%1.5 $1.65 1/15/202418,300 shares $33,855.00 -10.7%0.3%1.3 $1.85 12/31/202320,500 shares $36,080.00 -9.3%0.4%1.5 $1.76 12/15/202322,600 shares $44,748.00 -2.6%0.4%1.7 $1.98 11/30/202323,200 shares $52,432.00 +21.5%0.4%1.4 $2.26 11/15/202319,100 shares $42,020.00 +64.7%0.3%1 $2.20 10/31/202311,600 shares $26,448.00 -3.3%0.2%0.5 $2.28 10/15/202312,000 shares $30,720.00 -14.3%0.2%0.6 $2.56 9/30/202314,000 shares $38,570.00 -31.7%0.2%0.7 $2.76 9/15/202320,500 shares $69,290.00 -9.3%0.4%1 $3.38 8/31/202322,600 shares $64,862.00 -51.6%0.4%1.3 $2.87 8/15/202346,700 shares $104,608.00 +115.2%0.8%2.8 $2.24 7/31/202321,700 shares $44,919.00 +29.9%0.4%1.6 $2.07 7/15/202316,700 shares $31,730.00 -1.8%0.3%1.3 $1.90 6/30/202317,000 shares $32,470.00 -28.3%0.3%0.6 $1.91 6/15/202323,700 shares $46,452.00 -11.9%0.4%0.8 $1.96Market down? Do this now. (Ad)During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now, history is repeating itself. Here's the truth: Tariffs create uncertainty. Uncertainty drives investors to gold. And gold prices rise as a result. It's a cycle that's already beginning again—and it's your chance to profit. Why wait? Greed isn't always a bad thing—especially when it comes to protecting and growing your wealth. The smartest investors are already moving their money into gold, and you should too.Download your Free 2025 Gold Guide Now 5/31/202326,900 shares $43,847.00 -0.4%0.5%0.9 $1.63 5/15/202327,000 shares $56,160.00 -51.4%0.5%1 $2.08 4/30/202355,600 shares $145,060.40 +159.8%1.0%2 $2.61 4/15/202321,400 shares $41,730.00 -9.3%0.4%0.8 $1.95 3/31/202323,600 shares $43,660.00 -12.6%0.4%3.1 $1.85 3/15/202327,000 shares $41,040.00 +4.7%0.5%2.9 $1.52 2/28/202325,800 shares $45,150.00 -21.3%0.5%1 $1.75 2/15/202332,800 shares $58,712.00 -16.1%0.6%1.3 $1.79 1/31/202339,100 shares $69,207.00 +3.7%0.7%1.5 $1.77 1/15/202337,700 shares $61,451.00 -29.8%0.7%1.5 $1.63 12/30/202253,700 shares $77,865.00 -46.3%1.1%2.2 $1.45 12/15/2022100,000 shares $195,000.00 +498.8%2.0%4.2 $1.95 11/30/202216,700 shares $30,415.71 -4.6%0.3%1.6 $1.82 11/15/202217,500 shares $30,276.75 +5.4%0.4%1.6 $1.73 10/31/202216,600 shares $30,378.00 +9.2%0.3%1.4 $1.83 10/15/202215,200 shares $27,360.00 -14.6%0.3%1.1 $1.80 9/30/202217,800 shares $38,448.00 -21.9%0.4%1.1 $2.16 9/15/202222,800 shares $61,104.00 -8.1%0.5%0.9 $2.68 8/31/202224,800 shares $62,496.00 -31.7%0.5%0.7 $2.52 8/15/202236,300 shares $105,270.00 -36.9%0.7%0.6 $2.90 7/31/202257,500 shares $163,300.00 -25.3%1.1%0.1 $2.84 7/15/202277,000 shares $256,410.00 +49.8%1.5%0.2 $3.33 6/30/202251,400 shares $134,154.00 -42.6%1.0%0.1 $2.61 6/15/202289,500 shares $200,480.00 -50.9%1.6%0.2 $2.24 5/31/2022182,100 shares $460,713.00 +569.5%3.2%0.4 $2.53 5/15/202227,200 shares $67,456.00 -38.3%0.5%0.1 $2.48 4/30/202244,100 shares $129,213.00 -14.7%0.8%1 $2.93 4/15/202251,700 shares $177,331.00 -18.1%0.9%0.9 $3.43 3/31/202263,100 shares $252,400.00 -30.6%1.1%0.8 $4.00 3/15/202290,900 shares $289,971.00 +21.2%1.6%0.6 $3.19 2/28/202275,000 shares $313,500.00 +6.8%1.4%0.4 $4.18 2/15/202270,200 shares $351,000.00 -34.2%1.3%0.3 $5.00 1/31/2022106,600 shares $531,934.00 +2.8%1.9%0.4 $4.99 1/15/2022103,700 shares $547,536.00 +157.3%1.9%0.4 $5.28 12/31/202140,300 shares $229,710.00 No Change0.7%0.1 $5.70 INDP Short Interest - Frequently Asked Questions What is Indaptus Therapeutics' current short interest? Short interest is the volume of Indaptus Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 38,700 shares of INDP short. 0.36% of Indaptus Therapeutics' shares are currently sold short. Learn More on Indaptus Therapeutics' current short interest. What is a good short interest ratio for Indaptus Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INDP shares currently have a short interest ratio of 2.0. Learn More on Indaptus Therapeutics's short interest ratio. What is a good short interest percentage for Indaptus Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.36% of Indaptus Therapeutics' floating shares are currently sold short. Is Indaptus Therapeutics' short interest increasing or decreasing? Indaptus Therapeutics saw a decrease in short interest during the month of January. As of January 31st, there was short interest totaling 38,700 shares, a decrease of 41.7% from the previous total of 66,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Indaptus Therapeutics' float size? Indaptus Therapeutics currently has issued a total of 14,120,000 shares. Some of Indaptus Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Indaptus Therapeutics currently has a public float of 10,880,000 shares. How does Indaptus Therapeutics' short interest compare to its competitors? 0.36% of Indaptus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Indaptus Therapeutics: Q32 Bio Inc. (29.00%), BioVie Inc. (7.97%), Pluri Inc. (1.18%), Bullfrog AI Holdings, Inc. (7.61%), Incannex Healthcare Inc. (0.85%), Rallybio Co. (1.72%), ProMIS Neurosciences, Inc. (1.09%), Marinus Pharmaceuticals, Inc. (3.95%), Coeptis Therapeutics Holdings, Inc. (0.83%), Akari Therapeutics, Plc (1.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Indaptus Therapeutics stock? Short selling INDP is an investing strategy that aims to generate trading profit from Indaptus Therapeutics as its price is falling. INDP shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Indaptus Therapeutics? A short squeeze for Indaptus Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INDP, which in turn drives the price of the stock up even further. How often is Indaptus Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INDP, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies QTTB Short Interest Data BIVI Short Interest Data PLUR Short Interest Data BFRG Short Interest Data IXHL Short Interest Data RLYB Short Interest Data PMN Short Interest Data MRNS Short Interest Data COEP Short Interest Data AKTX Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INDP) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indaptus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Indaptus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INDP Stock Alerts